Latest debt-to-equity ratio
Propanc Biopharma Debt-to-equity ratio
Direct answer
Propanc Biopharma's debt-to-equity ratio is 5.3%.
The verified market snapshot reports 5.3%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 16, 2026.
Get free Propanc Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.3%
Explore related company data
View Propanc Biopharma's market capitalizationView Propanc Biopharma's p/e ratioView Propanc Biopharma's price-to-book ratioView Propanc Biopharma's return on equityView Propanc Biopharma's 52-week price rangeView Propanc Biopharma's profit marginView all Propanc Biopharma key metricsReturn to Propanc Biopharma profile